Teva’s Reformulated Levothyroxine Gets Approval from UK’s Commission on Human Medicines
UK drug advisory body Commission on Human Medicines (CHM) has permitted Teva to reintroduce levothyroxine tablets in the United Kingdom
Read moreUK drug advisory body Commission on Human Medicines (CHM) has permitted Teva to reintroduce levothyroxine tablets in the United Kingdom
Read moreEarlier today, the world’s largest drugmaker Pfizer declared that it triumphed in the lawsuit against generic drugmaker Teva Pharmaceuticals USA
Read moreEarlier on Monday, Bloomberg reported that the infringing of a US patent by Teva for the HIV drug Epzicom has
Read moreThe US District Court for the Eastern District of Texas has issued a positive judgment in the proceedings of a
Read moreAccording to an Oppenheimer analyst, Teva Pharmaceutical Industries Ltd. is fraught with rising challenges and ambiguity due to its multiple
Read moreTeva Pharmaceutical Industries Ltd. announced that a late-stage clinical trial comprising an experimental drug, laquinimod, for the oral treatment for
Read more